These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8683863)

  • 41. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
    Chen G; Shao Z; Jia H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
    Dinçol G; Aktan M; Diz-Küçükkaya R; Yavuz S; Nalçaci M; Oztürk S; Palanduz S; Doğan O; Ağan M
    Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematologic response in patients with aplastic anemia after long-term administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
    Yonekura S; Kawada H; Watanabe S; Masumoto A; Ogawa Y; Fukuda R; Nishihira H; Matsuyama S; Katoh S; Mouri H; Motomura S; Shionoya S; Hotta T
    Clin Ther; 1997; 19(6):1394-407. PubMed ID: 9444448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytokines in combination to treat radiation-induced myelosuppresssion: evaluation of SCF + glycosylated EPO + pegylated G-CSF as an emergency treatment in highly irradiated monkeys.
    Drouet M; Delaunay C; Grenier N; Garrigou P; Mayol JF; Hérodin F
    Haematologica; 2008 Mar; 93(3):465-6. PubMed ID: 18310540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporine and recombinant granulocyte colony-stimulating factor in severe aplastic anemia.
    Kojima S; Fukuda M; Miyajima Y; Matsuyama T
    N Engl J Med; 1990 Sep; 323(13):920-1. PubMed ID: 1697647
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia.
    Geissler K; Forstinger C; Kalhs P; Knöbl P; Kier P; Kyrle P; Lechner K
    Ann Intern Med; 1992 Aug; 117(3):223-5. PubMed ID: 1377461
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemia.
    Nachbaur D; Gratwohl A; Herold M; Tichelli A; Slanicka M; Nissen C; Niederwieser D; Speck B
    Ann Hematol; 1993 Feb; 66(2):71-5. PubMed ID: 8448242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful cytokine treatment of aplastic anemia following living-related orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
    Sato S; Fuchinoue S; Abe M; Kitajima K; Tojimbara T; Nakajima I; Agishi T; Shiraga H; Ito K; Takasaki K; Hashimoto E; Hayashi N; Tanaka K
    Clin Transplant; 1999 Feb; 13(1 Pt 1):68-71. PubMed ID: 10081639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia.
    Bessho M; Toyoda A; Itoh Y; Sakata T; Kawai N; Jinnai I; Saito M; Hirashima K
    Br J Haematol; 1992 Mar; 80(3):409-11. PubMed ID: 1374630
    [No Abstract]   [Full Text] [Related]  

  • 52. Therapeutic value of interleukin-3 given alone or in combination with other cytokines.
    Ganser A; Hoelzer D
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):245-6. PubMed ID: 8337137
    [No Abstract]   [Full Text] [Related]  

  • 53. [61-year-old patient with hemorrhagic diathesis and fatigue].
    Schleuning M; Thomssen C; Kolb HJ; Sauer H; Wilmanns W
    Internist (Berl); 1993 Dec; 34(12):1141-5. PubMed ID: 7508900
    [No Abstract]   [Full Text] [Related]  

  • 54. Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia.
    Olivieri NF; Feig SA; Valentino L; Berriman AM; Shore R; Freedman MH
    Blood; 1994 May; 83(9):2444-50. PubMed ID: 8167334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of recombinant human interleukin-3 in aplastic anemia.
    Ganser A; Lindemann A; Seipelt G; Ottmann OG; Eder M; Falk S; Herrmann F; Kaltwasser JP; Meusers P; Klausmann M
    Blood; 1990 Oct; 76(7):1287-92. PubMed ID: 2207306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Stimulation of myelopoiesis by G-CSF (Filgastrim) in a case oc severe aplastic anemia].
    Domingo JM; Palomera L; Ansó V; Agulló JA; Olave MT
    Sangre (Barc); 1993 Dec; 38(6):501-2. PubMed ID: 7513445
    [No Abstract]   [Full Text] [Related]  

  • 57. Recombinant human interleukin-3 in refractory severe aplastic anaemia: a phase I/II trial.
    Bargetzi MJ; Gluckman E; Tichelli A; Devergie A; Esperou H; Kabata J; Wodnar-Filipowicz A; Nissen C; Speck B; Gratwohl A
    Br J Haematol; 1995 Oct; 91(2):306-12. PubMed ID: 8547066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of refractory severe aplastic anemia with granulocyte colony stimulating factor and interleukin 3.
    Schleuning M; Thomssen C; Kolb HJ; Sauer HJ; Wilmanns W
    Am J Hematol; 1994 Jul; 46(3):250-1. PubMed ID: 7514849
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical application of erythropoietin].
    Bessho M
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):839-43. PubMed ID: 8753049
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful treatment of aplastic anemia with G-CSF and high dose erythropoietin.
    Nishii K; Suzuki Y; Minami N; Titley I; Kita K; Shiku H
    Leuk Lymphoma; 1998 Jun; 30(1-2):211-4. PubMed ID: 9669693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.